China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical observation of trilaciclib for secondary prophylaxis of myelosuppression in solid tumor chemotherapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130364
Registration Time: 2026/08/19
Type: Interventional study
Primary Sponsor: Hefei First People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=331976
Published by HT Digital Content Services with permission from Health Daily Digest....